Quantitative Investment Management, LLC Biogen Inc. Transaction History

Quantitative Investment Management, LLC

$1.02 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $4.53 Million - $5.72 Million	21,371 New	21,371 $4.61 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $2.68 Million - $3.25 Million	10,611 New	10,611 $2.94 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.33 Million - $1.58 Million	-7,078 Reduced 33.85%	13,832 $2.82 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $4.05 Million - $5.1 Million	20,910 New	20,910 $4.4 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $5.33 Million - $6.85 Million	-23,817 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $1.64 Million - $2.13 Million	-5,778 Reduced 19.52%	23,817 $6.74 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $6.46 Million - $10.3 Million	24,927 Added 534.0%	29,595 $10.2 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $1.13 Million - $1.33 Million	4,668 New	4,668 $1.31 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $9.14 Million - $12.1 Million	-35,343 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $9.5 Million - $12.1 Million	35,343 New	35,343 $11.2 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $21.2 Million - $29.3 Million	-96,396 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $21 Million - $23.5 Million	96,396 New	96,396 $22.4 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $8.96 Million - $10.7 Million	-34,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $9.05 Million - $12.8 Million	34,800 New	34,800 $9.53 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $44.8 Million - $50.1 Million	-145,500 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $40.9 Million - $48 Million	145,500	145,500 $45.6 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.

Account